Clinical Trials on Glabellar Crease

Total 10000 results

UNICANCER

Active, not recruiting

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment (ASTER 70s)

Breast Cancer

France, Belgium
UNICANCER
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis (DAISY)

Breast Tumors

France
Fudan University

Active, not recruiting

Prepectoral and Subpectoral Implant-based Breast Reconstruction

Breast Carcinoma | Breast Reconstruction

China
Dana-Farber Cancer Institute
Patient-Centered Outcomes Research Institute

Active, not recruiting

Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

Breast Cancer

United States
Sichuan Provincial People's Hospital

Completed

Clinical Study of 18F-FAPI-RGD in Breast Tumors

Breast Tumors

China
State University of New York - Upstate Medical...

Completed

Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant

Breast Tumors

United States
Mary Radomski

Completed

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups (CC-V)

Breast Cancer | Breast Neoplasm

United States
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...

Enrolling by invitation

Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery (ESPECS)

Breast Cancer | Breast Neoplasms | Breast Carcinoma

Italy
St. Joseph Hospital of Orange

Withdrawn

Microwave Ablation of Breast Tumors

Breast Cancer

United States
Duke University
National Institutes of Health (NIH); National Institute for Biomedical Imaging...

Completed

A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins

Breast Cancer

United States
InSightec

Completed

Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas

Breast Cancer
Massachusetts General Hospital

Completed

Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant

Breast Cancer

United States
Washington University School of Medicine

Completed

Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP) (FFNP)

Breast Cancer

United States
Jules Bordet Institute

Completed

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. (EC2075)

Breast Cancer.

Belgium
AirXpanders, Inc.

Completed

Study of AeroForm Tissue Expander for Breast Reconstruction (ASPIRE)

Breast Cancer | Breast Reconstruction

Australia
National University Hospital, Singapore

Unknown

Biomarker Study of Breast Tumors

Breast Tumors

Singapore
National Cancer Institute (NCI)

Completed

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Breast Cancer | Breast Neoplasm

United States
Baylor Breast Care Center

Terminated

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

BREAST CANCER

United States
National Institutes of Health Clinical Center (CC)

Completed

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Breast Cancer | Breast Neoplasm

United States
UNICANCER
University of Warwick

Not yet recruiting

Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests (OPTIMA-YOUNG)

Early Breast Cancer | Premenopausal Breast Cancer | HR+/HER2- Breast Cancer

Spain, France, Belgium, Italy, Poland, Ireland, Greece
Fudan University

Not yet recruiting

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Triple-Negative Breast Cancer

China
Tongji Hospital

Recruiting

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Breast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast Cancer

China
Hebei Medical University Fourth Hospital
Beijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Breast Cancer | Triple-negative Breast Cancer | Nab-paclitaxel

China
Dana-Farber Cancer Institute
Pfizer

Completed

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Breast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Triple-negative Breast Cancer

United States
National Cancer Institute (NCI)

Completed

VEGF Trap in Treating Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Ohio State University Comprehensive Cancer Center
American Association for Cancer Research

Recruiting

The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Hormone Receptor-Positive Breast Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast Carcinoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast Carcinoma

United States, Puerto Rico, Ireland
National Cancer Institute (NCI)

Completed

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma

United States
Washington University School of Medicine
The Foundation for Barnes-Jewish Hospital

Active, not recruiting

Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma (BreaStBRT)

Breast Cancer | Breast Carcinoma | Stage 0 Breast Cancer | Stage I Breast Cancer

United States
Dana-Farber Cancer Institute
The Comprehensive and Integrative Medicine Institute of South Korea

Completed

Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) (PACT)

Breast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast Cancer

United States
Ono Pharmaceutical Co. Ltd

Active, not recruiting

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Metastatic Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

Japan
Veana Therapeutics
University of Washington

Suspended

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast Carcinoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions
Shanghai Henlius Biotech

Not yet recruiting

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Breast Cancer (Triple Negative Breast Cancer (TNBC))

China
Pengfei Qiu

Not yet recruiting

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)

China
Harbin Medical University

Not yet recruiting

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer (TNBC)
Memorial Sloan Kettering Cancer Center
Gateway for Cancer Research

Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
Shanghai Proton and Heavy Ion Center

Recruiting

A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.

Breast Cancer

China
Guangdong Provincial People's Hospital
Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou...

Recruiting

Organoid-based Functional Precision Therapy for Advanced Breast Cancer (ORIENTA)

Advanced Breast Cancer | HER2-negative Breast Cancer

China
Universitair Ziekenhuis Brussel
eTheRNA immunotherapies

Recruiting

Intratumoral TriMix Injections in Early Breast Cancer Patients (TMBA)

Breast Cancer Female | Early-stage Breast Cancer

Belgium
Spotlight Medical
Austrian Breast & Colorectal Cancer Study Group

Active, not recruiting

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

Breast Cancer | Early Breast Cancer | ER-Positive HER2-Negative Breast Cancer

Austria
Carrick Therapeutics Limited
Berlin-Chemie AG Menarini Group

Completed

A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (SUMIT-ELA)

Breast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer

United States, France, Spain, United Kingdom
AstraZeneca
Daiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, Limited

Active, not recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer (DB-08)

Metastatic Breast Cancer

Belgium, United States, Taiwan, France, Brazil, Canada, Australia, Mexico, South Korea, Russia
Centre Leon Berard
Amgen

Active, not recruiting

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (BREASTIMMU02)

HER2-positive Breast Cancer | Operable Breast Cancer

France
Bolt Biotherapeutics, Inc.
Hoffmann-La Roche

Terminated

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer

Spain, United States
National Cancer Center, Korea

Completed

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Greece, Cyprus

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations